A critical review of midazolam 10 mg autoinjector for the treatment of convulsive status epilepticus in adults.
Expert Review of Neurotherapeutics · 2026-03-28 · Other / unclear
Abstract
INTRODUCTION: Status epilepticus is a neurological emergency in which rapid treatment is essential to reduce morbidity and mortality. Delays in establishing intravenous access frequently hinder timely benzodiazepine administration, creating a critical need for fast, reliable, and user-friendly non-IV rescue therapies. The midazolam 10 mg autoinjector was developed to address these operational barriers and improve prehospital seizure management. AREAS COVERED: This review examines the pharmacology, clinical efficacy, safety, and regulatory status of the midazolam autoinjector, drawing on published studies of intramuscular midazolam, pharmacokinetic evaluations of autoinjector formulations, and regulatory documents supporting its approval. EXPERT OPINION: The midazolam autoinjector offers a meaningful advance in the treatment of status epilepticus by enabling rapid, consistent intramuscular delivery without preparation. Its design directly addresses the practical limitations of existing therapies and is likely to encourage adoption in prehospital and other time-critical settings. As emergency care increasingly prioritizes early intervention, autoinjector-based benzodiazepines are poised to play an expanding role in modern seizure-rescue strategies.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Sedatives & anxiolytics · Midazolam · Other benzodiazepines & Z-drugs
Related articles
- [S2k guidelines: status epilepticus in adulthood : Guidelines of the German Society for Neurology]. (Nervenarzt, 2021)
- Intramuscular midazolam versus intravenous clonazepam for prehospital treatment of generalized tonic-clonic seizures: A randomized double-blind non-inferiority trial. (Seizure, 2026)
- Treating status epilepticus in clinical practice-a multi-national survey in Germany, Austria, and Switzerland. (Front Neurol, 2025)
- Effectiveness of Ketamine As a Rescue Drug for Patients Experiencing Benzodiazepine-Resistant Status Epilepticus in the Prehospital Setting. (Crit Care Explor, 2024)
- Challenges of status epilepticus management in a resource-limited setting: A review. (IBRO Neurosci Rep, 2024)
- Early and established status epilepticus: The impact of timing of intervention, treatment escalation and dosing on outcome. (Seizure, 2023)